Ifupinostat
Ifupinostat is a drug used for the treatment of cancer. It is approved in China for adults with relapsed or refractory diffuse large B-cell lymphoma who have received at least two lines of systemic therapy. It is being developed by BeBetter Med.
Ifupinostat acts as both a phosphoinositide 3-kinase α inhibitor and a histone deacetylase inhibitor.